Human mast cells (HMC-1 5C6) enhance interleukin-6 production by quiescent and lipopolysaccharide-stimulated human coronary artery endothelial cells

Mediators Inflamm. 2012:2012:274347. doi: 10.1155/2012/274347. Epub 2012 Jan 26.

Abstract

We examined the effect of intact human mast cells (HMC-1 5C6) and their selected mediators on interleukin-6 (IL-6) production and bone morphogenetic protein-2 (BMP-2) expression in human coronary artery endothelial cells (HCAEC) in the presence and absence of lipopolysaccharide (LPS). Scanning electron microscopy showed that HMC-1 5C6 cells adhere to HCAEC in cocultures. Addition of HMC-1 5C6 cells markedly enhanced the IL-6 production by quiescent and LPS-activated HCAEC even at the maximal concentration of LPS. Furthermore, mast cell-derived histamine and proteases accounted for the direct and synergistic effect of mast cells on IL-6 production that was completely blocked by the combination of histamine receptor-1 antagonist and protease inhibitors. Another novel finding is that histamine was able to induce BMP-2 expression in HCAEC. Collectively, our results suggest that endotoxin and mast cell products synergistically amplify vascular inflammation and that histamine participates in the early events of vascular calcification.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Blotting, Western
  • Bone Morphogenetic Protein 2 / genetics
  • Bone Morphogenetic Protein 2 / metabolism
  • Cell Communication / genetics
  • Cell Communication / physiology
  • Cells, Cultured
  • Coronary Vessels / cytology*
  • Endothelial Cells / cytology*
  • Endothelial Cells / drug effects*
  • Humans
  • Interleukin-6
  • Lipopolysaccharides / pharmacology*
  • Mast Cells / cytology*
  • Mast Cells / metabolism*
  • Real-Time Polymerase Chain Reaction

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Interleukin-6
  • Lipopolysaccharides